This is the authors' abstract. We don't add key points for this paper.
The patients with HLA-DQ7 and HLA-DQ9 mismatches exhibit the highest risk of developing dnDSAs. Individualized immunosuppression adjustment and kidney allocation based on specific HLA-DQ mismatch may enhance long-term graft survival.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Skulratanasak et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: